Grants
Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.
Displaying 241 - 250 of 339 results
-
Harnessing potent next-generation diarylquinolines for long-acting injectable formulations to prevent and treat tuberculosis (Assist # 830011)
Date:
06/25/2021Topics:
Lead Investigators:
-
Modulation of Herpes Simplex Virus Pathogenesis by Leucine Rich Repeat Kinase 2
Date:
06/11/2021Lead Investigators:
-
A Phase 2, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Omadacycline in Adult Subjects with Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by Mycobacterium abscessus complex (MABc)
Date:
06/01/2021Topics:
Lead Investigators:
-
Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance and Other Adverse Events
Date:
06/01/2021Locations:
Lead Investigators:
-
Johns Hopkins Prevention Epicenter: Transdisciplinary Research Approaches to Prevent Healthcare Associated Infections and Antibiotic Resistance (TRAP)
Date:
06/01/2021Lead Investigators:
-
Characterization of plasma virome in people who inject drugs to identify early transmission networks of HIV and other bloodborne infections
Date:
05/15/2021Topics:
Lead Investigators:
-
Immunologic and Metabolic Profiles of T cells that control diverse HCV infections
Date:
05/01/2021Topics:
Lead Investigators:
-
Mechanisms of antibody-mediated control of repeated hepatitis C virus infection in humans
Date:
05/01/2021Topics:
Lead Investigators:
-
Building the Next Generation of Researchers in HIV/TB Diagnostics in Mali (B-NextGen)
Date:
05/01/2021Locations:
Topics:
Lead Investigators:
-
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
Date:
05/01/2021Topics:
Lead Investigators: